Idiopathic dilated cardiomyopathy: Familial prevalence and HLA distribution

Heart

Volumn 77, Issue 6, 1997, Pages 549-552

  McKenna, C J ^a,c   Codd, M B ^b   McCann, H A ^a   Sugrue, D D ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Dept of Epidemiol and Biostatist ^*

^c MAYO CLINIC   (United States)

Author keywords

HLA DR4; Idiopathic dilated cardiomyopathy; Screening

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

EID: 0030871639     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.6.549     Document Type: Article

References (23)

1. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44: 672-3.
2. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 1996;93: 841-2.
3. Anderson JL, Carlquist JF, Lutz JR, DeWitt CW, Hammond EH. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol 1984;53:1326-30.
4. Caforio ALP, Bonifacio E, Stewart JT, et al. Novel organspecific autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15:1527-34.
5. Michels W, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77-82.
6. Keeling PJ, Gang Y, Smith G, et al. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995; 73:417-21.
7. Caforio ALP, Keeling PJ, Zachara E, et al. Evidence from familial studies for autoimmunity in dilated cardiomyopathy. Lancet 1994;344:773-7.
8. Michels W, Moll PP, Rodeheffer RJ, et al. Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy. Mayo Clin Proc 1994;69:24-7.
9. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980;62:1054-61.
10. Goerss JB, Michels VV, Burnett JB, et al. Frequency of familial dilated cardiomyopathy. Eur Heart J 1995;16: 2-4S.
11. Sugrue DD, Holmes DR, Gersh BJ, et al. Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol 1984; 4:952-7.
12. Limas CJ, Limas C. HLA antigens in idiopathic dilated cardiomyopathy. Br Heart J 1989;62:379-83.
13. Arbustini E, Gavazzi A, Pozzi R, et al. The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am J Cardiol 1989;64:991-5.
14. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Circulation 1991;83:515-22.
15. Martinetti M, Dugoujon JM, Caforio ALP, et al. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy. Hum Immunol 1992;35:193-9.
16. Bland NK, Schwimmbeck PL, Kuhl U, Enczmann J, Wernet P. HLA DR association in myocarditis and dilated cardiomyopathy. Circulation 1992;86-I:794.
17. Limas C, Limas CJ, Boudoulas H, et al. Anti-β-receptor antibodies in familial cardiomyopathy: correlation with HLA-DR and HLA-DQ gene polymorphism. Am Heart J 1994;127:382-6.
18. Grant SCD, Sheldon S, Dyer PA, Levy RD, Brooks NH. Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy? Br Heart J 1994;71:76-8.
19. Smith JD, Rose ML, Pomerance A, Burke M, Yacoub MH. Reduction in cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995;346:1318-22.
20. Anderson JL, Carlquist JF, Hammond EH. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet 1982;ii:1124-7.
21. Huber KC, Gersh BJ, Sugrue DD, et al. T-lymphocyte subsets in patients with idiopathic dilated cardiomyopathy. Int J Cardiol 1989;22:59-66.
22. Herskowitz A, Ahmed-Ansari A, Neumann DA, et al. Induction of major histocompatibility antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 1990; 15:624-32.
23. Limas CL, Limas CJ, Boudoulas H, et al. T-cell receptor gene polymorphisms in familial cardiomyopathy: correlation with anti-β-receptor autoantibodies. Am Heart J 1992;124:1258-63.